查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190795

外骨骼市場 - 增長、趨勢、COVID-19 的影響、預測 (2023-2028)

Exoskeleton Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

外骨骼市場預計到 2021 年將達到 3.5422 億美元，到 2027 年將達到 16.2004 億美元，在預測期間（2022-2027 年）以 12.5% 的複合年增長率增長。

COVID-19 大流行是一個前所未有的健康問題，並造成了重大挫折。 這種流行病對全球外骨骼市場產生了重大影響。 在治療有持續性殘疾和運動問題的 COVID-19 患者中，外骨骼的使用越來越多。 例如，根據 2020 年發表的一篇題為“在 COVID-19 期間使用外骨骼輔助重症監護病房俯臥位”的研究論文，使用外骨骼支撐腰部是有充分理由的。初步證實， 該研究發現，即使在 COVID-19 大流行的背景下，使用外骨骼來協助醫務人員也是有用且容易實現的。 根據 2021 年題為“在俯臥位操作期間使用被動背部支撐外骨骼的生物力學效應”的研究論文，在 COVID-19 流行期間使用外骨骼協助醫務人員是有用且易於實現的。 根據一篇題為“初步研究”的研究論文，在 COVID-19 大流行期間，重症監護病房 (ICU) 的工作人員對大量患有急性呼吸窘迫綜合徵 (ARDS) 的插管患者進行了一天的俯臥位 (PP)。 “我不得不這樣做很多次。 在這項研究中，我們闡明了使用 Laevo 可以減少俯臥位操作期間的腰椎肌肉骨骼負荷，而不會引起嚴重的副作用或改變臨床實踐。 在這項研究中，兩台 Laevo 被部署在 Centre Hospitalier Regional Universitaire de Nancy (CHRU Nancy) 的重症監護室，並成功使用了 6 個月。 因此，大流行期間對外骨骼的需求是巨大的。 未來，由於解除封鎖和開發疫苗，預計作為康復一部分的外骨骼的需求將會增加。 然而，根據 Ekso Bionics 的 2020 年年度報告，外骨骼產品的需求在大流行期間暴跌了 38.0%，導致 2020 年有 61 筆預訂，而 2019 年為 98 筆。

推動市場增長的主要因素是中風患病率的上升、外骨骼的日益普及以及全球老年人口的增加。 隨著殘疾人和老年人數量的增加，全球對使用機器人進行康復的需求正在增加。 近年來，隨著老齡化社會的推進，對物理治療服務的需求增加。 此外，隨著中風等疾病的存活率提高，技術在醫療保健中的作用也越來越明顯。 因此，機器人康復和輔助技術有望減輕物理治療師的負擔，降低成本，同時提高患者的生活質量。

隨著全球殘疾人數量的增加，對此類機器人康復設備的需求也越來越大。 例如，聯合國估計到2050年世界老年人口將達到21億。 人口老齡化和健康狀況長期惡化正在增加殘疾人的比例。 因此，機器人康復的應用隨著這些系統的市場而迅速增長。 一個例子是麥吉爾大學開發的一種機器人，它可以幫助坐輪椅的病人走路。 支持步態訓練和神經康復。 其他研究人員和公司也在開發使用機器人技術和 3D 打印的產品，以幫助患有脊髓損傷、中風、帕金森病和多發性硬化症導致的行動障礙的患者。 許多醫院已經開始在他們的康復中心使用機器人技術。 主要市場參與者的產品發布和創新也是市場增長的原因之一。 例如，2020 年 2 月，Ekso Bionics 宣布與 Kindred Healthcare 合作，在長期急症護理醫院試點 EksoNR。 同樣，2020 年 1 月，Bionik 實驗室宣布其 InMotion 手臂機器人技術在韓國的獨家經銷商獲得監管批准並首次銷售。 因此，所有這些因素都有望推動整個市場。

主要市場趨勢

在預測期內，按產品類型劃分，移動細分市場預計將佔據最大份額

用戶暫時佩戴康復醫學外骨骼以提高性能。 因此，用戶不再按照指示的訓練方案使用該外骨骼。 康復外骨骼必須是可調節的，一遍又一遍地進行精確的動作，並記錄每個患者的信息。 主要供下肢運動障礙患者使用 1-2 小時。 通過使用康復設備，您將能夠正確行走。 推動該行業增長的主要因素是殘疾人人數的增加和市場參與者實施戰略舉措。

根據2019年發表的一篇題為《下肢康復外骨骼機器人綜述》的文章，中國是世界上中風發病率最高的國家。 近1500萬腦癱、偏癱、截癱等下肢運動功能障礙患者和近4000萬老年殘疾人因衰老喪失行走能力。 因此，下肢康復機器人在我國具有重大意義。 康復機器人的使用可以減輕治療師的負擔，實現訓練過程中的數據檢測，以可控、可重現的方式輔助量化評估康復情況。 一些市場參與者正在為市場增長做出貢獻。 例如，2021 年 3 月，致力於康復和輔助機器人的醫療保健初創公司 Astrek Innovations 宣布，其產品開發已進入最後階段，預計將於 2021 年第二季度開始用戶測試。 基於 Gurugram 的加速器 Huddle 正在加速產品開發。 Astrek 的 Unik Exosuit 系列是電動可穿戴機器人，可以幫助下肢殘疾者進行步態訓練和鍛煉。

因此，預計上述因素將在預測期內推動市場增長。

預計在預測期內北美將佔據很大的市場份額

佔據北美市場很大份額的主要因素包括患者的高購買力、日益老齡化的人口以及補貼和資助技術先進產品開發的公共和私人組織。

根據國家脊髓損傷中心的 SCI 數據表，到 2020 年，美國每年將記錄大約 17,810 例新的脊髓損傷，其中男性約佔新的脊髓損傷 (SCI) 病例的 78% SCI Statistics (NSCISC). 我來了。 美國大約有 294,000 名脊髓損傷患者。 目前受傷時的平均年齡是 43 歲。 在醫院急症監護病房的住院時間縮短至 11 天（約 1 個半星期），在康復中心的住院時間縮短至 31 天（約 1 個月）。 同樣，美國疾病控制與預防中心 (CDC) 於 2020 年 9 月發布的最新消息發現，26% 的美國成年人患有某種形式的殘疾。 因此，這些統計數據推動多個市場參與者實施其戰略舉措。

研發活動正在推動市場增長。 例如，根據美國國家標準與技術研究院 (NIST) 2020 年 8 月的更新，為了幫助製造商和消費者降低與外骨骼相關的風險，美國國家標準與技術研究院的研究人員已經確定了外骨骼，我們已經開發了一種新的測量方法來測試佩戴它的人是否動作流暢。 產品發布也是市場增長的原因之一。 例如，2021 年 3 月，Ekso Bionics 與 Physiotry USA 合作，向醫生宣傳 EksoNR 外骨骼的臨床益處。 這種夥伴關係將有助於提高醫生和其他康復治療師對 Ekso Bionics 技術的認識。 您還將學習如何成功地將機器人技術整合到您的康復計劃中。

因此，預計這些因素將在預測期內顯著推動市場增長。

競爭格局

市場適度盤整。 市場上的主要參與者包括 Cyber□□dyne、Ekso Bionics Holdings、Rewalk Robotics、Bionik Laboratories 等。 因此，這些參與者增加對開發創新產品的投資以及 FDA 對其產品的批准正在支持市場的增長。 例如，2020年1月，Bioservo Technologies宣布推出Ironhand 1.6版本，優化患者用戶體驗。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 醫療保健領域對機器人康復的需求不斷擴大
    • 機器人技術的進步
    • 大力投資開發外骨骼技術
  • 市場製約因素
    • 由於模糊的安全指南而導致使用外骨骼的相關風險
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按治療類型
    • 康復
    • 加固處理
  • 按身體部位
    • 上半身
    • 下半身
  • 按產品類型
    • 固定式
    • 手機
  • 按地區查看
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Cyberdyne Inc.
    • Ekso Bionics Holdings
    • Rewalk Robotics
    • Bionik Laboratories Corp.
    • Parker-Hannifin Corp.
    • Bioservo Technologies AB
    • Gogoa Mobility Robots
    • Rehab-Robotics Company Limited
    • Bioness Inc.
    • B-Temia Inc.

第7章 市場機會與今後動向

簡介目錄
Product Code: 62300

The exoskeleton market was valued at USD 354.22 million in 2021, and it is expected to reach USD 1620.04 million in 2027, registering a CAGR of 12.5% during the forecast period (2022-2027).

The COVID-19 pandemic is an unprecedented health concern, causing a huge setback. The pandemic significantly impacted the exoskeleton market worldwide. The use of exoskeletons is increasing in the management of COVID-19 patients with prolonged disability and problems in movement. For instance, as per a research article published in 2020, titled "The use of exoskeletons to help with prone positioning in the intensive care unit during COVID-19", the preliminary results confirmed that the use of an exoskeleton for lumbar support is fully justified. The study states that using an exoskeleton to assist medical staff could be helpful and readily feasible, even in the context of the COVID-19 pandemic. As per a research article published in 2021, titled "Biomechanical effects of using a passive back support exoskeleton during prone-positioning maneuver: A pilot study", during the COVID-19 pandemic, intensive care unit (ICU) staff had to perform prone-positioning (PP) of a large number of intubated patients suffering from acute respiratory distress syndrome (ARDS) many times a day. The study revealed that using the Laevo could help reduce the musculoskeletal load on the lower back during prone positioning maneuvers without causing any significant negative side effects or modifying the practice. The study states that two Laevos were successfully deployed in intensive care units of Centre Hospitalier Regional Universitaire de Nancy (CHRU Nancy), and they were used for six months. Thus, the demand for exoskeletons was significant during the pandemic. With the removal of lockdowns and the development of vaccines, the demand for exoskeletons as a part of rehabilitation is expected to increase. However, as per Ekso Bionics' 2020 annual report, the demand for exoskeleton products dramatically decreased by 38.0% during the onset of the pandemic, leading to the booking of 61 units in 2020 compared to 98 units in 2019.

The major factors propelling the market's growth are the rising prevalence of stroke, increasing adoption of the exoskeleton, and the growing geriatric population at a global level. With the increasing number of disabled and aged people, there has been an increase in the demand for robotic rehabilitation worldwide. In recent years, the demand for physical therapy services has grown, partly because of the aging population. The role of technology in healthcare has become evident with the enhanced rate of survival from medical disorders, such as stroke. Therefore, robotic rehabilitation and assistive technologies promise to ease the stress on the physiotherapy staff and control expenses while refining patients' quality of life.

There has been a growing demand for these robotic rehabilitation devices that are showing an upward trajectory as the prevalence of disability worldwide is increasing. For example, the United Nations estimates that the global geriatric population will reach 2.1 billion by 2050. The rates of disability are increasing due to the aging population and an increase in chronic health conditions. Therefore, the applications of robotic rehabilitation are growing fast with the market for these systems. One example is a robot developed at McGill University that helps patients who use wheelchairs to walk. It supports gait training and neuro-rehabilitation. Other researchers and companies are also developing products using robotics and 3D printing to help patients with movement disorders from an impaired spinal cord or due to stroke, Parkinson's disease, and multiple sclerosis. Numerous hospitals started using robotics within their rehabilitation centers. Product launches and innovations through key market players are another reason for the market's growth. For instance, in February 2020, Ekso Bionics announced a collaboration with Kindred Healthcare to pilot EksoNR in long-term acute care hospitals. Similarly, in January 2020, Bionik laboratories announced the regulatory approval and the first sale of its InMotion arm robotic technology by its exclusive distributor in South Korea. Hence, all these factors are expected to drive the overall market.

Key Market Trends

The Mobile Segment is Expected to Hold the Largest Share by Product Type Over the Forecast Period

The user wears rehabilitation medical exoskeletons temporarily to improve performance. Therefore, the user no longer uses this exoskeleton following a supervised training regimen. A rehabilitation exoskeleton must be adjustable and must execute the exact motion many times and log the information for each patient. It is used by a patient in 1- to 2-hour sessions, mainly those with lower limb movement disorders. After using the rehabilitation devices, the patient starts to walk properly. The major factors fueling the segment's growth are the increasing prevalence of disability and the implementation of strategic initiatives by the market players.

As per an article titled "A Review on Lower Limb Rehabilitation Exoskeleton Robots", published in 2019, China had the highest stroke rate globally. There were nearly 15 million disabled people with lower limb motor dysfunctions, such as cerebral palsy, hemiplegia, and paraplegia, and nearly 40 million disabled older adults had lost the ability to walk due to aging. Therefore, lower limb rehabilitation robots are of great significance in China. The use of rehabilitation robots can reduce the burden on therapists, realize data detection during training, and aid the quantitative evaluation of recovery in a controllable and repeatable manner. Several market players are contributing to the market's growth. For instance, in March 2021, Astrek Innovations, a healthcare start-up working with rehabilitation and assistive robotics, announced that it is in the last stages of product development and planned to begin user trials in the second quarter of 2021. The product development is accelerated by the Gurugram-based accelerator, Huddle. Astrek's Unik Exosuit range is a motorized wearable robot that can help people with lower limb disabilities in gait training and performing exercises.

Hence, the factors mentioned above are expected to drive the market's growth during the forecast period.

North America is Expected to Hold a Significant Market Share Over the Forecast Period

The key factors responsible for the large share of the North American market include the high purchasing power of patients, the growing geriatric population, and the public and private organizations offering grants and funds for the development of technologically advanced products.

According to the SCI Data Sheet from the National SCI Statistical Center (NSCISC), 2020, around 17,810 new spinal cord injuries are recorded each year in United States, among which males account for about 78% of new spinal cord injury (SCI) cases. Approximately 294,000 people with SCI live in United States. The current average age at the time of injury is 43 years old. Lengths of stay in the hospital acute care unit declined to 11 days (about one and a half weeks), and lengths of stay in rehabilitation declined to 31 days (about one month). Similarly, according to a September 2020 update by the Centers for Disease Control and Prevention (CDC), 26% of adults in United States had some type of disability. Thus, due to these statistics, several market players are engaged in the implementation of strategic initiatives.

The increasing R&D is driving the market's growth. For instance, as per an August 2020 update by the National Institute of Standards and Technology (NIST), to help manufacturers and consumers mitigate the risks associated with exoskeletons, researchers at the National Institute of Standards and Technology developed a new measurement method to test whether an exoskeleton and the person wearing it are moving smoothly. Product launches are another reason for the market's growth. For instance, in March 2021, Ekso Bionics partnered with the US Physiatry to educate physicians on the clinical benefits of an EksoNR exoskeleton. The partnership will help raise awareness of the Ekso Bionics technology among physicians and other rehabilitation therapists. It will also teach them how to successfully integrate robotics into rehabilitation programs.

Thus, such factors are expected to boost the market's growth significantly over the forecast period.

Competitive Landscape

The market is moderately consolidated. Some of the key players in the market are Cyberdyne, Ekso Bionics Holdings, Rewalk Robotics, and Bionik Laboratories. Therefore, the increasing investments by these players in the development of new and innovative products and the FDA approvals of their products are supporting the market's growth. For example, in January 2020, Bioservo Technologies announced the launch of its Ironhand 1.6 version for an optimized user experience for its patients.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand from Healthcare Sector for Robotic Rehabilitation
    • 4.2.2 Advancement in Robotic Technologies
    • 4.2.3 Huge Investment for the Development of the Exoskeleton Technology
  • 4.3 Market Restraints
    • 4.3.1 Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Treatment Type
    • 5.1.1 Rehabilitation
    • 5.1.2 Augmentation
  • 5.2 By Body Part Type
    • 5.2.1 Upper Body
    • 5.2.2 Lower Body
  • 5.3 By Product Type
    • 5.3.1 Stationary
    • 5.3.2 Mobile
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cyberdyne Inc.
    • 6.1.2 Ekso Bionics Holdings
    • 6.1.3 Rewalk Robotics
    • 6.1.4 Bionik Laboratories Corp.
    • 6.1.5 Parker-Hannifin Corp.
    • 6.1.6 Bioservo Technologies AB
    • 6.1.7 Gogoa Mobility Robots
    • 6.1.8 Rehab-Robotics Company Limited
    • 6.1.9 Bioness Inc.
    • 6.1.10 B-Temia Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS